These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6330134)

  • 21. Biochemical and functional study of antithrombin III in newborn infants.
    McDonald MM; Hathaway WE; Reeve EB; Leonard BD
    Thromb Haemost; 1982 Feb; 47(1):56-8. PubMed ID: 7071806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of horse plasma antithrombin III and alpha 1-proteinase inhibitor with some serine proteinases.
    Koj A; Kurdowska A
    Acta Biol Med Ger; 1981; 40(10-11):1561-70. PubMed ID: 6979142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of thrombin-antithrombin III complex with vitronectin in serum.
    Ill CR; Ruoslahti E
    J Biol Chem; 1985 Dec; 260(29):15610-5. PubMed ID: 2415521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-association of antithrombin III relates to multimer formation of thrombin-antithrombin III complexes.
    Preissner KT
    Thromb Haemost; 1993 May; 69(5):422-9. PubMed ID: 8322264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of thrombin-induced proteoglycan release in the degradation of human and bovine cartilage.
    Furmaniak-Kazmierczak E; Cooke TD; Manuel R; Scudamore A; Hoogendorn H; Giles AR; Nesheim M
    J Clin Invest; 1994 Aug; 94(2):472-80. PubMed ID: 8040300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and characterization of rat plasma antithrombin III.
    Takahara H; Sinohara H
    Biochim Biophys Acta; 1980 Mar; 612(1):185-94. PubMed ID: 7362830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor-mediated activation of murine peritoneal macrophages by antithrombin III acts as a costimulatory signal for nitric oxide synthesis.
    Kwak JY; Park SY; Han MK; Lee HS; Sohn MH; Kim UH; McGregor JR; Samlowski WE; Yim CY
    Cell Immunol; 1998 Aug; 188(1):33-40. PubMed ID: 9743555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction of immobilized thrombin with human antithrombin III.
    Marciniak E; Gora-Maslak G
    Thromb Haemost; 1984 Feb; 51(1):27-31. PubMed ID: 6719385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
    Hoylaerts M; Holmer E; de Mol M; Collen D
    Thromb Haemost; 1983 Apr; 49(2):109-15. PubMed ID: 6868006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of proplatelet formation (PPF) stimulating factor: thrombin/antithrombin III complex stimulates PPF of megakaryocytes in vitro and platelet production in vivo.
    Ishida Y; Yano K; Ito T; Shigematus H; Sasaki K; Kondo S; Kuriya S
    Thromb Haemost; 2001 Feb; 85(2):349-55. PubMed ID: 11246559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and isolation of a 45-kDa calcium-dependent lactoferrin receptor from rat hepatocytes.
    Bennatt DJ; McAbee DD
    Biochemistry; 1997 Jul; 36(27):8359-66. PubMed ID: 9204883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of antithrombin III.protease complex metabolism by fibroblasts and vascular endothelial cells.
    Savion N; Farzame N
    Thromb Res; 1986 Feb; 41(4):459-70. PubMed ID: 3515618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated rat hepatocytes bind lactoferrins by the RHL-1 subunit of the asialoglycoprotein receptor in a galactose-independent manner.
    Bennatt DJ; Ling YY; McAbee DD
    Biochemistry; 1997 Jul; 36(27):8367-76. PubMed ID: 9204884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of antithrombin III and thrombin to immobilized heparin under flow conditions.
    Byun Y; Jacobs HA; Kim SW
    Biotechnol Prog; 1996; 12(2):217-25. PubMed ID: 8857192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences between fluid-phase endocytosis (pinocytosis) and receptor-mediated endocytosis in isolated rat hepatocytes.
    Strømhaug PE; Berg TO; Gjøen T; Seglen PO
    Eur J Cell Biol; 1997 May; 73(1):28-39. PubMed ID: 9174669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic changes produced by complex formation between thrombin and antithrombin-III.
    McDuffie FC; Peterson JM; Clark G; Mann KG
    J Immunol; 1981 Jul; 127(1):239-44. PubMed ID: 6787123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Processing of carcinoembryonic antigen by Kupffer cells: recognition of a penta-peptide sequence.
    Gangopadhyay A; Thomas P
    Arch Biochem Biophys; 1996 Oct; 334(1):151-7. PubMed ID: 8837750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo catabolism of heparin cofactor II and its complex with thrombin: evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitors.
    Pratt CW; Church FC; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):111-7. PubMed ID: 3258496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.